These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 2906343)
1. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene. Lepot MR; Gaspard UJ Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343 [TBL] [Abstract][Full Text] [Related]
2. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related]
3. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study. Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913 [TBL] [Abstract][Full Text] [Related]
4. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546 [TBL] [Abstract][Full Text] [Related]
5. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
7. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel. Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560 [TBL] [Abstract][Full Text] [Related]
8. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol. Bonnar J; Daly L; Carroll E Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344 [TBL] [Abstract][Full Text] [Related]
9. Clinical and metabolic effects of gestodene and levonorgestrel. Rabe T; Runnebaum B; Kohlmeier M; Harenberg J; Weicker H Int J Fertil; 1987; 32 Suppl():29-44. PubMed ID: 2906345 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148 [TBL] [Abstract][Full Text] [Related]
11. Effects of three low-dose oral contraceptive formulations on lipid metabolism. Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417 [TBL] [Abstract][Full Text] [Related]
12. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580 [TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen. Nash AL; Cornish EJ; Hain R Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411 [TBL] [Abstract][Full Text] [Related]
14. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Larsson-Cohn U; Wallentin L; Zador G Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252 [TBL] [Abstract][Full Text] [Related]
15. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters. Winkler UH; Sudik R Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism. Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546 [TBL] [Abstract][Full Text] [Related]
17. Effect of two monophasic oral contraceptives containing gestodene or desogestrel on serum lipoprotein lipid levels. Leuven JA; de Pagter HA; Dersjant-Roorda MA; Helmerhorst FA; Roelofsen J Int J Fertil; 1989 Sep; 34 Suppl():55-60. PubMed ID: 2576261 [TBL] [Abstract][Full Text] [Related]
18. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters. Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein alterations from a triphasic oral contraceptive containing ethinyl estradiol and gestodene. A 12-month trial. Moutos DM; Zacur HA; Bachorik PS; Wallach EE J Reprod Med; 1994 Sep; 39(9):720-4. PubMed ID: 7807486 [TBL] [Abstract][Full Text] [Related]
20. Long-term profile of a new progestin. Lippman J Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]